Loading clinical trials...
Loading clinical trials...
The purpose of this research study is to compare the growth and tolerance of infants who consume either an infant formula with intact proteins or an infant formula with partially hydrolyzed proteins t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mead Johnson Nutrition
NCT05967689 · Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
NCT07333521 · Isolated Non-acquired Growth Hormone Deficiency
NCT06948214 · Growth Hormone Deficiency (GHD)
NCT07025031 · Idiopathic Fetal Growth Restriction
NCT07222215 · Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, and more
Birmingham Pediatric Associates
Birmingham, Alabama
Southeastern Pediatric Associates
Dothan, Alabama
Visions Clinical Research-Tucson
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions